HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ulrike Billmeier Selected Research

Therapeutics

1/2019Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn's disease.
1/2018Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases.
11/2016Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases.
12/2015First case report of exacerbated ulcerative colitis after anti-interleukin-6R salvage therapy.
4/2015From physiology to disease and targeted therapy: interleukin-6 in inflammation and inflammation-associated carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ulrike Billmeier Research Topics

Disease

5Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018 - 11/2011
5Inflammation (Inflammations)
11/2016 - 11/2011
4Crohn Disease (Crohn's Disease)
01/2019 - 03/2014
3Ulcerative Colitis
05/2020 - 12/2015
2Colitis
05/2020 - 11/2011
1Necrosis
01/2019
1Rheumatoid Arthritis
11/2016
1Pancreatitis
03/2016
1Ulcer
12/2015
1Carcinogenesis
04/2015
1Neoplasms (Cancer)
04/2015
1Infections
01/2015
1Arthritis (Polyarthritis)
09/2013
1Experimental Arthritis
09/2013
1Insulin Resistance
03/2013
1Autoimmune Diseases (Autoimmune Disease)
11/2011

Drug/Important Bio-Agent (IBA)

4AntibodiesIBA
01/2019 - 03/2014
4CytokinesIBA
01/2018 - 11/2011
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2016 - 09/2013
2Interleukin-6 (Interleukin 6)IBA
12/2015 - 04/2015
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
05/2020
1OligonucleotidesIBA
05/2020
1Phenobarbital (Luminal)FDA Link
05/2020
1cobitolimodIBA
05/2020
1Toll-Like Receptor 9IBA
05/2020
1Dextrans (Dextran)FDA Link
05/2020
1DNA (Deoxyribonucleic Acid)IBA
05/2020
1Interleukin-10 (Interleukin 10)IBA
05/2020
1Type II Tumor Necrosis Factor ReceptorsIBA
01/2019
1Interleukin-23 (Interleukin 23)IBA
01/2019
1vedolizumabIBA
01/2018
1IntegrinsIBA
01/2018
1Etanercept (Enbrel)FDA Link
11/2016
12-mercaptopurineIBA
10/2016
1ChromatinIBA
03/2016
1geranylgeranyltransferase type-I (protein geranylgeranyltransferase)IBA
02/2016
1EnzymesIBA
02/2016
1Adalimumab (Humira)FDA Link
12/2015
1tocilizumab (atlizumab)FDA Link
12/2015
1Infliximab (Remicade)FDA Link
12/2015
1Azathioprine (Imuran)FDA LinkGeneric
12/2015
1Methotrexate (Mexate)FDA LinkGeneric
12/2015
1SteroidsIBA
12/2015
1Tacrolimus (Prograf)FDA LinkGeneric
12/2015
1Antimicrobial PeptidesIBA
01/2015
1Glucose (Dextrose)FDA LinkGeneric
03/2013
1Transcription Factors (Transcription Factor)IBA
03/2013
1Complement 3d Receptors (Complement Receptor 2)IBA
11/2011
1Interleukin-27 (Interleukin 27)IBA
11/2011
1Proteins (Proteins, Gene)FDA Link
11/2011
1InterleukinsIBA
11/2011
1Interleukin-12 (IL 12)IBA
11/2011

Therapy/Procedure

5Therapeutics
01/2019 - 04/2015
2Precision Medicine
11/2016 - 03/2014
1Colectomy
12/2015
1Intravenous Infusions
12/2015
1Salvage Therapy
12/2015
1Lasers (Laser)
03/2014